Clinical research

DOI: 10.4244/EIJ-D-22-00609

Long-term outcomes of peripheral atherectomy for femoropopliteal endovascular interventions

Anna K. Krawisz1,2,3, MD; Aishwarya Raja4, MD; W. Schuyler Jones5, MD; Peter Schneider6, MD; Changyu Shen1, PhD; Marc Schermerhorn7, MD; Eric A. Secemsky1,2,3, MD, MSc

Abstract

Background: The use of atherectomy during peripheral endovascular interventions (PVI) has increased dramatically, but data regarding its safety and effectiveness are lacking. 

Aims: This study sought to determine the long-term safety of atherectomy in contemporary practice. 

Methods: Medicare fee-for-service beneficiaries who underwent femoropopliteal artery PVI from 2015-2018 were identified in a 100% sample of inpatient, outpatient, and carrier file data using procedural claims codes. The primary exposure was the use of atherectomy. Inverse probability of treatment weighting was used to adjust for measured differences in patient populations. Kaplan-Meier methods and multivariable Cox proportional hazards regression were used to compare outcomes. 

Results: Among 168,553 patients who underwent PVI, 59,142 (35.1%) underwent atherectomy. The mean patient age was 77.0±7.6 years, 44.9% were female, 81.9% were white, and 46.7% had chronic limb-threatening ischaemia. Over a median follow-up time of 993 days (interquartile range 319-1,377 days), atherectomy use was associated with no difference in the risk of either the composite endpoint of death and amputation (adjusted hazard ratio [aHR] 0.99, 95% confidence interval [CI]: 0.97-1.01; p=0.19) or of major adverse limb events...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 18 Number 16
Apr 3, 2023
Volume 18 Number 16
View full issue


Key metrics

On the same subject

Clinical research

10.4244/EIJ-D-23-00432 Dec 18, 2023
Outcomes of atherectomy in patients undergoing lower extremity revascularisation
Albaghdadi M et al

Clinical research

10.4244/EIJ-D-19-00693 Jun 25, 2021
Outcomes of directional atherectomy for common femoral artery disease
Böhme T et al
free

Clinical research

10.4244/EIJ-D-20-01018 Sep 20, 2021
Long-term safety of drug-coated devices for peripheral revascularisation
Secemsky E et al
free

Clinical Research

10.4244/EIJ-D-21-01070 Aug 5, 2022
Phoenix atherectomy for patients with peripheral artery disease
Giusca S et al
free

Editorial

10.4244/EIJ-E-22-00046 Dec 2, 2022
Drug-coated balloons in the real world: do they hold up?
Secemsky E and Korjian S
free

Clinical research

10.4244/EIJ-D-19-01031 Aug 6, 2021
Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries
Tamez H et al
free
Trending articles
281.53

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved